X0508 4 2026-01-09 0 0001819576 Liquidia Corp LQDA 0001935638 Saggar Rajeev 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 0 1 0 0 Chief Medical Officer 1 Common Stock 2026-01-09 4 M 0 3531 A 180080 D Common Stock 2026-01-09 4 M 0 17945 A 198025 D Common Stock 2026-01-12 4 S 0 21142 37.43 D 176883 D Performance Stock Units 2026-01-09 4 M 0 3531 0 D Common Stock 3531 28246 D Performance Stock Units 2026-01-09 4 M 0 17945 0 D Common Stock 17945 53835 D Performance stock units ("PSUs") convert into common stock on a one-for-one basis. On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 28,246 have vested as of the date of this Form 4. Includes (i) 20,833 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 28,246 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 53,835 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025 and (iv) 2,221 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 17,945 have vested as of the date of this Form 4. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. /s/ Dr. Rajeev Saggar 2026-01-13